These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Can common-type atrial flutter be a sign of an arrhythmogenic substrate in paroxysmal atrial fibrillation? Clinical and ablative consequences in patients with coexistent paroxysmal atrial fibrillation/atrial flutter. Moreira W, Timmermans C, Wellens HJ, Mizusawa Y, Philippens S, Perez D, Rodriguez LM. Circulation; 2007 Dec 11; 116(24):2786-92. PubMed ID: 18040030 [Abstract] [Full Text] [Related]
24. [Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study]. Zhang HC, Guo JH, Fang Q, Zheng YA, Sun YM, Zhu WQ, Wan Z, Guo JX, Ge JB, Han SM. Zhonghua Yi Xue Za Zhi; 2005 Mar 30; 85(12):798-801. PubMed ID: 15949393 [Abstract] [Full Text] [Related]
25. Emergency Department Re-Presentation for Atrial Fibrillation and Atrial Flutter. Redfearn DP, Furqan MA, Enriquez A, Barber D, Shaw C, Simpson C, Baranchuk A, Michael K, Abdollah H, Brison RJ. Can J Cardiol; 2016 Mar 30; 32(3):344-8. PubMed ID: 26683789 [Abstract] [Full Text] [Related]
27. Increased risk of sudden and non-sudden cardiovascular death in patients with atrial fibrillation/flutter following acute myocardial infarction. Pedersen OD, Abildstrøm SZ, Ottesen MM, Rask-Madsen C, Bagger H, Køber L, Torp-Pedersen C, TRACE Study Investigators. Eur Heart J; 2006 Feb 30; 27(3):290-5. PubMed ID: 16267070 [Abstract] [Full Text] [Related]
28. Atrial fibrillation requiring urgent medical care. Approach and outcome in the various departments of admission. Data from the atrial Fibrillation/flutter Italian REgistry (FIRE). Santini M, De Ferrari GM, Pandozi C, Alboni P, Capucci A, Disertori M, Gaita F, Lombardi F, Maggioni AP, Mugelli A, Salerno-Uriarte JA, Sermasi S, Schwartz PJ, FIRE Investigators. Ital Heart J; 2004 Mar 30; 5(3):205-13. PubMed ID: 15119503 [Abstract] [Full Text] [Related]
30. CHA2DS2-VASc predicts readmission, outcomes and resource utilization in patients undergoing coronary artery bypass grafting: A 7-year National Readmission Database study. Wafa SEI, Sawatari H, Ahmed R, Deshpande S, Khan H, Providencia R, Padmanabhan D, Somers VK, Ramphul K, Awad W, Chahal CAA, Khanji MY. Int J Cardiol; 2024 Dec 15; 417():132529. PubMed ID: 39244101 [Abstract] [Full Text] [Related]
31. [Modulation of atrioventricular conduction in patients with atrial fibrillation or flutter. Immediate and long-term results]. Carbucicchio C, Lavarra F, Riva S, Fassini G, Della Bella P. Cardiologia; 1995 Dec 15; 40(12):927-40. PubMed ID: 8901043 [Abstract] [Full Text] [Related]
32. National assessment of Medicare prescription plan coverage gaps among patients with atrial fibrillation in the US. Kim MH, Lin J, Kreilick C. Adv Ther; 2009 Aug 15; 26(8):784-94. PubMed ID: 19690820 [Abstract] [Full Text] [Related]
34. Association between statin therapy and reductions in atrial fibrillation or flutter and inappropriate shock therapy. Bhavnani SP, Coleman CI, White CM, Clyne CA, Yarlagadda R, Guertin D, Kluger J. Europace; 2008 Jul 15; 10(7):854-9. PubMed ID: 18495672 [Abstract] [Full Text] [Related]
37. The need for atrial flutter ablation following pulmonary vein antrum isolation in patients with and without previous cardiac surgery. Kilicaslan F, Verma A, Yamaji H, Marrouche NF, Wazni O, Cummings JE, Hao S, Andrews MW, Beheiry S, Abdul-Karim A, Belden WA, Minor S, Burkhardt JD, Saliba W, Schweikert RA, Natale A. J Am Coll Cardiol; 2005 Mar 01; 45(5):690-6. PubMed ID: 15734612 [Abstract] [Full Text] [Related]
38. A review of the appropriate and inappropriate use of dronedarone: lessons learned from controlled studies and regulatory submission. Naccarelli GV, Wolbrette DL, Samii S, Banchs JE, Penny-Peterson E, Gonzalez MD. J Cardiovasc Pharmacol Ther; 2010 Dec 01; 15(4 Suppl):24S-30S. PubMed ID: 21098416 [Abstract] [Full Text] [Related]